Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rona Lujan"'
Autor:
Yuri Gorelik, Itai Ghersin, Deema Shlon, Chagit Friss, Rona Lujan, Yiska Loewenberg Weisband, Shira Greenfeld, Revital Kariv, Natan Ledderman, Eran Matz, Iris Dotan, Haggai Bar-Yoseph, Yehuda Chowers, Dan Turner
Publikováno v:
Journal of Crohn's and Colitis.
Background Different antibiotic classes were reported to have variable effects on immunogenicity towards anti-tumour necrosis factor [TNF] agents. However, the impact of antibiotic administration on biologic treatment durability was not investigated.
Autor:
Oren Ledder, Sasha Harel, Rona Lujan, Chagit Friss, Esther Orlanski-Meyer, Dotan Yogev, Yiska Loewenberg Weisband, Shira Greenfeld, Revital Kariv, Natan Lederman, Eran Matz, Doron Schwartz, Gili Focht, Iris Dotan, Dan Turner
Publikováno v:
Inflammatory Bowel Diseases.
Background Timely access to quality medical care impacts patient outcomes in inflammatory bowel disease (IBD). In a nationwide study from the epidemiology group of the Israeli IBD research nucleus we aimed to assess the impact of residence and socioe
Autor:
Ohad Atia, Esther Orlanski-Meyer, Rona Lujan, Natan Ledderman, Shira Greenfeld, Revital Kariv, Saleh Daher, Henit Yanai, Yiska Loewenberg Weisband, Hagit Gabay, Eran Matz, Daniel Nevo, Jacob Ollech, Eran Zittan, Eran Israeli, Doron Schwartz, Yehuda Chowers, Iris Dotan, Dan Turner
Publikováno v:
Journal of Crohn's and Colitis. 16:796-803
Background It is still of debate whether the advent of biologics has been associated with a change in the natural history of ulcerative colitis [UC]. In this nationwide study we evaluated trends of long-term outcomes in all patients diagnosed with UC
Autor:
Doron Schwartz, Saleh Daher, Esther Orlanski-Meyer, N Ledderman, Revital Kariv, Dan Turner, Yiska Loewenberg Weisband, Daniel Nevo, Iris Dotan, Henit Yanai, Eran Israeli, Ohad Atia, E Matz, S Greenfeld, Hagit Gabay, Yehuda Chowers, Rona Lujan
Publikováno v:
Journal of Crohn's and Colitis. 16:778-785
Background The effectiveness of biologics for improving long-term outcomes in patients with Crohn’s disease [CD] is still controversial. In this nationwide study, we aimed to evaluate trends of long-term outcomes in all CD patients in Israel during
Autor:
Raffi Lev-Tzion, Gili Focht, Rona Lujan, Adi Mendelovici, Chagit Friss, Shira Greenfeld, Revital Kariv, Amir Ben-Tov, Eran Matz, Daniel Nevo, Yuval Barak-Corren, Iris Dotan, Dan Turner
Publikováno v:
Clinical Gastroenterology and Hepatology
Studies have shown decreased response to coronavirus disease 2019 (COVID-19) vaccinations in some populations. In addition, it is possible that vaccine-triggered immune activation could trigger immune dysregulation and thus exacerbate inflammatory bo
Autor:
Dana Ben Hur, Guy Issaschar, Ran Moshe, Rona Lujan, Gili Focht, Revital Kariv, Eran Matz, Dan Turner, Gabriel D. Pinto, Matti Waterman
Publikováno v:
Gastroenterology. 162:S-636
Autor:
Rona Lujan, Dan Turner, Ran D. Balicer, Ohad Atia, Noa Asayag, Iris Dotan, Gili Focht, Revital Kariv, Ziona Haklai, Oren Ledder, Hagit Gabay, Daniel Nevo, S Greenfeld
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 20(3)
Limited population-based data have explored perianal involvement in Crohn's disease (CD) and compared the disease course between severe and non-severe perianal CD (PCD). We aimed to explore the disease course of these phenotypes in a population-based